ENTITY

BioLine RX (BLRX US)

9
Analysis
Health CareIsrael
BioLineRx Ltd. is a biopharmaceutical development company. The Company develops clinical-stage therapeutic pharmaceutical drugs.
more
bullishBioLine RX
03 Jun 2025 03:00Issuer-paid

BLRX: First Quarter Results

BioLineRx is a commercial stage biopharmaceutical company with a development portfolio advancing motixafortide, a platform molecule targeting...

Share
bullishBioLine RX
28 May 2025 22:00Issuer-paid

BLRX: First Quarter Results

BioLineRx is a commercial stage biopharmaceutical company with a development portfolio advancing motixafortide, a platform molecule targeting...

Share
bullishBioLine RX
03 Apr 2025 23:00Issuer-paid

BLRX: 2024 Financial Results

BioLineRx is a commercial stage biopharmaceutical company with a development portfolio advancing motixafortide, a platform molecule targeting...

Share
bullishBioLine RX
19 Feb 2025 23:00Issuer-paid

BLRX: Aphexda Transition Progressing

BioLineRx is a commercial stage biopharmaceutical company with a development portfolio advancing motixafortide, a platform molecule targeting...

Share
bullishBioLine RX
04 Dec 2024 06:00Issuer-paid

BLRX: Ayrmid Assumes Commercialization Efforts

BioLineRx is a commercial stage biopharmaceutical company with a development portfolio advancing motixafortide, a platform molecule targeting...

Share
x